J M Goldman

发表

Assessment of brain changes with registered MR before and after bone marrow transplantation for chronic myeloid leukemia.

J V Hajnal, G M Bydder, H R Jäger, 1996, AJNR. American journal of neuroradiology.

Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia.

F Lanza, F. Lanza, S. Bi, 1993, Leukemia.

Chronic myelogenous leukemia: biology and therapy.

E. Canaani, R. Gale, G. Grosveld, 1993, Leukemia.

T-lymphoblastic Leukaemia: A Distinct Variant of Acute Leukaemia

D. Catovsky, D. Galton, J. Goldman, 1974, British medical journal.

Summary curves for patients transplanted for chronic myeloid leukaemia salvaged by a donor lymphocyte infusion: the current leukaemia‐free survival curve

J P Klein, N Keiding, N. Keiding, 2000, British journal of haematology.

Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings.

J P Klein, J J van Rood, F H Bach, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

J Hermans, G. Gahrton, A. Gratwohl, 1998, Lancet.

Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.

A Ferrant, D. Niederwieser, J. Goldman, 1995, Blood.

1,25-dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells.

H Zola, D. Catovsky, H. Zola, 1983, Leukemia research.

Estimation of current leukaemia-free survival following donor lymphocyte infusion therapy for patients with leukaemia who relapse after allografting: application of a multistate model.

J P Klein, J. Klein, C. Craddock, 2000, Statistics in medicine.

Diverging effects of HLA–DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles

S Mackinnon, N H Russell, J A Madrigal, 2010, Leukemia.

Estimating leukemia-free survival after allografting for chronic myeloid leukemia: a new method that takes into account patients who relapse and are restored to complete remission.

J P Klein, J. Klein, C. Craddock, 2000, Blood.